Top

Published in:

01-01-2019

Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation

Authors: G. P. T. Areas, A. Mazzuco, F. R. Caruso, R. B. Jaenisch, R. Cabiddu, S. A. Phillips, R. Arena, A. Borghi-Silva

Published in: Heart Failure Reviews | Issue 1/2019

Abstract

Endothelial dysfunction plays as an important role on mismatch responses that occur during exercise in patients with congestive heart failure (CHF). However, cardiac rehabilitation, a core component of management of CHF patients, can improve endothelial function, contributing to reduce the morbidity and mortality of these patients. The primary aims of this review were to describe the importance of flow-mediated dilatation (FMD) as a non-invasive validation tool to assess endothelial dysfunction and to highlight the relevance of scientific studies that evaluated the effects of exercise interventions on peripheral vascular endothelial function as measured by FMD in patients with CHF with both preserved and reduced ejection fraction.

Vanhoutte PM, Shimokawa H, Tang EH, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxford) 196(2):193–222

Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Phys 250(6 Pt 2):H1145–H1149

Dharmashankar K, Welsh A, Wang J, Kizhakekuttu TJ, Ying R, Gutterman DD, Widlansky ME (2012) Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function. Am J Hypertens 25(5):528–534PubMedPubMedCentral

Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, Goodfellow J (2001) Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 101(6):629–635

Landmesser U, Hornig B, Drexler H (2004a) Endothelial function: a critical determinant in atherosclerosis? Circulation 109(21 Suppl 1):II27–II33PubMed

Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H (2004b) Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110(14):1933–1939PubMed

Miura H, Wachtel RE, Liu Y, Loberiza FR Jr, Saito T, Miura M, Gutterman DD (2001) Flow-induced dilation of human coronary arterioles: important role of ca (2+)-activated K(+) channels. Circulation 103(15):1992–1998PubMed

Phillips SA, Hatoum OA, Gutterman DD (2007a) The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. Am J Physiol Heart Circ Physiol 292(1):H93–H100PubMed

de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, Stroes ES (2002) Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 163(1):193–197PubMed

10.

Gokce N, Holbrook M, Hunter LM, Palmisano J, Vigalok E, Keaney JF Jr, Vita JA (2002a Aug 21) Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol 40(4):761–765PubMed

11.

Gokce N, Vita JA, Bader DS, Sherman DL, Hunter LM, Holbrook M, O'Malley C, Keaney JF Jr, Balady GJ (2002b) Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 90(2):124–127PubMed

12.

Liu Y, Gutterman DD (2009) Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol 104(3):211–227PubMedPubMedCentral

13.

Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K, Kim S, Toba K, Yoshizumi M, Ouchi Y (1999) Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 19(11):2795–800

14.

Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G (2011) Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57(3):363–369PubMed

15.

Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115PubMed

16.

Anderson TJ, Phillips SA (2015) Assessment and prognosis of peripheral artery measures of vascular function. Prog Cardiovasc Dis 57(5):497–509PubMed

17.

Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) International brachial artery reactivity task force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39(2):257–265PubMed

18.

Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300(1):H2–H12PubMed

19.

Green DJ, Dawson EA, Groenewoud HM, Jones H, Thijssen DH (2014) Is flow-mediated dilation nitric oxide mediated? A meta-analysis. Hypertension 63(2):376–382PubMed

20.

Greyling A, Van Mil AC, Zock PL, Green DJ, Ghiadoni L, Thijssen DH (2016) TIFN international working group on flow mediated dilation. Adherence to guidelines strongly improves reproducibility of brachial artery flow-mediated dilation. Atherosclerosis 248:196–202PubMed

21.

Yeboah J, Burke GL, Crouse JR, Herrington DM (2008) Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the cardiovascular health study. Atherosclerosis 97(2):840–845

22.

Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL, Herrington DM (2011) Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA). J Hum Hypertens 25(1):25–31PubMed

23.

Palmer RIM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526PubMed

24.

Busse R, Mulsch A, Fleming I, Hecker M (1993) Mechanisms of nitric oxide release from the endothelium. Circulation 5:S18–S25

25.

Moncada S (1994) Physiology effects of nitric oxide. J Hypertens 2:35–39

26.

Philips AS, Mahmoud AM, Brown MD, Haus JM (2015) Exercise interventions and peripheral arterial function: Implecations for cardio-metabolic disease. Prog Cardiovasc Dis 57:521–534

27.

Negrão CE, Rondon MU, Tinucci T, Alves MJ, Roveda F, Braga AM, Reis SF, Nastari L, Barretto AC, Krieger EM, Middlekauff HR (2001) Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol 280(3):1286–1292

28.

Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Phys Cell Phys 292(1):C82–C97

29.

Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Möbius-Mikler S, Schubert A, Schuler G (2005) Hambrecht R. A ntioxidative effects of exercise training in patients with chronic heart failure increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111:1763–1770PubMed

30.

Brandes RP, Kreuzer J (2005) Vascular NADPH oxidase: molecular mechanisms of activation. Cardiovasc Res 65:16–27PubMed

31.

Lang CC, Rayos GH, Chomsky DB, Wood AJJ, Wilson JR (1997) Effects of sympathoinhibition on exercise performance in patients with HF. Circulation 96:238–245PubMed

32.

Shoemaker JK, Naylor HL, Hogemen CD, Sinoway LI (1999) Blood flow dynamics in HF. Circulation 238:238–245

33.

Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GD, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823PubMed

34.

Esler M, Kaye D (2000) Measurement of sympathetic nervous system activity in heart failure: the role of noripinephrinekinects. Heart Fail Rev 5:17–25PubMed

35.

Watson AM, Hood SG, May CN (2006) Mechanisms of sympa- thetic activation in heart failure. Clin Exp Pharmacol Physiol 33:1269–1274PubMed

36.

Santos AC, Alves MJ, Rondon MU, Barreto AC, Middlekauff HR, Negrao CE (2005) Sympathetic activation retrains endothelium – mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol 289:H593–H599PubMed

37.

Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H (2005a) Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65–69PubMed

38.

Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D (2009) Vascular endotelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure†. Eur J Heart Fail 11(6):588–593PubMed

39.

Meyer B, Mörtl D, Strecker K, Hülsmann M, Kulemann V, Neunteufl T, Pacher R, Berger R (2005) Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 46:1011–1018PubMed

40.

Takishima I, Nakamura T, Hirano M, Kitta Y, Kobayashi T, Fujioka D, Saito Y, Watanabe K, Watanabe Y, Mishina H, Obata JE, Kawabata K, Tamaru S, Kugiyama K (2012) Predictive value of serial assessment of endothelial function in chronic heart failure. Int J Cardiol 158(3):417–422PubMed

41.

TarroGenta F, Eleuteri E, Temporelli PL, Comazzi F, Tidu M, Bouslenko Z, Bertolin F, Vigorito C, Giannuzzi P, Giallauria F (2013) Flow-mediated dilation normalization predicts outcome in chronic heart failure patients. J CardFail 19(4):260–267

42.

Klosinska M, Rudzinski T, Grzelak P, Stefanczyk L, Drozdz J, Krzeminska-Pakula M (2009) Endothelium-dependent and -independent vasodilation is more attenuated in ischaemic than in non-ischaemic heart failure. Eur J Heart Fail 11(8):765–770PubMed

43.

Shah A, Gkaliagkousi E, Ritter JM, Ferro A (2010) Endothelial function and arterial compliance are not impaired in subjects with heart failure of non-ischemic origin. J Card Fail 16(2):114–120PubMed

44.

Ciccone MM, Iacoviello M, Puzzovivo A, Scicchitano P, Monitillo F, De Crescenzo F, Caragnano V, Sassara M, Quistelli G, Guida P, Favale S (2011) Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 100(6):515–521PubMed

45.

Paine NJ, Hinderliter AL, Blumenthal JA, Adams KF Jr, Sueta CA, Chang PP, O'Connor CM, Sherwood A (2016) Reactive hyperemia is associated with adverse clinical outcomes in heart failure. Am Heart J 178:108–114PubMedPubMedCentral

46.

Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115(24):3086–3094PubMed

47.

Guazzi M, Casali M, Berti F, Rossoni G, Colonna VD, Guazzi MD (2008) Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients. Clin Pharmacol Ther 83(2):336–341PubMed

48.

Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O'Keefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012) Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension 60(3):659–668PubMedPubMedCentral

49.

Zuo L, Chuang CC, Hemmelgarn BT, Best TM (2015) Heart failure with preserved ejection fraction: Defining the function of ROS and NO. J Appl Physiol (1985) 119(8:)944–951

50.

Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83:59–115PubMed

51.

Ferrari R, Bachetti T, Agnoletti L, Comini L, Curello S (1998) Endothelial function and dysfunction in heart failure. Eur Heart J 19 SupplG:G41–G47

52.

Lam CS, Roger VL, Rodeheffer RJ, Francesca Bursi F, Barry A, Borlaug BA, Ommen SR et al (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115:1982–1990PubMedPubMedCentral

53.

Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R (1995) Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76:980–986PubMed

54.

Khan BV, Harrison DG, Olbrych MT, Alexander MW, Medford RM (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redoxsensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A 93:9114–9119PubMedPubMedCentral

55.

Niu XF, Smith CW, Kubes P (1994) Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133–1140PubMed

56.

Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J et al (2005) Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on Endothelins and endothelial factors of the European Society of Hypertension. J Hypertens 23:233–246PubMed

57.

Carsten T, Van Linthout S (2014) New insights in (inter) cellular mechanisms by heart failure with preserved ejection fraction. Curr Heart Fail Rep 11:436–444

58.

Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM et al (2007) TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/ reperfusion injury. Arterioscler Thromb Vasc Biol 27:1269–1275PubMed

59.

Spillmann F, Van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP et al (2014) LXR agonism improves TNF-alpha-induced endothelial dysfunction in the absence of its cholesterol-modulating effects. Atherosclerosis 232:1–9PubMed

60.

Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T et al (2012) Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 60:1778–1786PubMed

61.

Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494–501PubMed

62.

Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschope C (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4(1):44–52PubMed

63.

Poole DC, Hirai DM, Copp SW, Musch TI (2012) Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol 302(5):H1050–H1063PubMed

64.

Downing J, Balady GJ (2011) The role of exercise training in heart failure. J Am Coll Cardiol 58(6):561–569PubMed

65.

Ramos JS, Dalleck LC, Tjonna AE, Beetham KS, Coombes JS (2015) The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Med 45(5):679–692PubMed

66.

Hornig B, Maier V, Drexler H (1996) Physical training improves endothelial function in patients with chronic heart failure. Circulation 93:210–214PubMed

67.

Kobayashi N, Tsuruya Y, Iwasawa T, Ikeda N, Hashimoto S, Yasu T, Ueba H, Kubo N, Fujii M, Kawakami M, Saito M (2003) Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities. Circ J 67:505–510PubMed

68.

Erbs S, Höllriegel R, Linke A, Beck EB, Adams V, Gielen S, Möbius-Winkler S, Sandri M, Kränkel N, Hambrecht R, Schuler G (2010) Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail 3(4):486–494PubMed

69.

Vuckovic KM, Piano MR, Phillips SA (2013 May) Effects of exercise interventions on peripheral vascular endothelial vasoreactivity in patients with heart failure with reduced ejection fraction. Heart Lung Circ 22(5):328–340PubMedPubMedCentral

70.

Pearson MJ, Smart NA (2017) Aerobic training intensity for improved endothelial function in heart failure patients: a systematic review and meta-analysis. Cardiol Res Pract 2017:1–10

71.

Ashor AW, Lara J, Siervo M, Celis-Morales C, Oggioni C, Jakovljevic DG, Mathers JC (2015 Feb) Exercise modalities and endothelial function: a systematic review and dose-response meta-analysis of randomized controlled trials. Sports Med 45(2):279–296PubMed

72.

Haykowsky MJ, Tomczak CR, Scott JM, Paterson DI, Kitzman DW (2015) Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction. J Appl Physiol (1985) 119(6):739–744

73.

Kitzman DW, Brubaker PH, Herrington DM, Morgan TM, Stewart KP, Hundley WG, Abdelhamed A, Haykowsky MJ (2013) Effect of endurance exercise training on endothelial function and arterial stiffness in olderpatients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol 62(7):584–592PubMedPubMedCentral

74.

Haykowsky MJ, Herrington DM, Brubaker PH, Morgan TM, Hundley WG, Kitzman DW (2013) Relationship of flow mediated arterial dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. J Gerontol A Biol Sci Med Sci 68:161–167PubMed

75.

Kitzman DW, Haykowsky MJ (2016) Vascular dysfunction in heart failure with preserved ejection fraction. J Card Fail 22(1):12–16PubMed

76.

Lee JF, Barrett-O'Keefe Z, Garten RS, Nelson AD, Ryan JJ, Nativi JN, Richardson RS, Wray DW (2016) Evidence of microvascular dysfunction in heart failure with preserved ejection fraction. Heart 102(4):278–284PubMed

77.

Angadi SS, Mookadam F, Lee CD, Tucker WJ, Haykowsky MJ, Gaesser GA (2015) High-intensity interval training vs. moderate intensity continuous exercise training in heart failurewith preserved ejection fraction: a pilot study. J Appl Physiol (1985) 119(6):753–758

78.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847PubMed

79.

McAlister FA, Ezekowitz J, Hooton N et al (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297:2502–2514PubMed

80.

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549PubMed

81.

Yu CM, Gorcsan J 3rd, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, Fung JW et al (2007) Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol 100:1263–1270PubMed

82.

Akar JG, Al-Chekakie MO, Fugate T et al (2008) Endothelial dysfunction in heart failure identifies responders to cardiac resynchronization therapy. Heart Rhythm 5:1229–1235PubMed

83.

AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR et al (2009) Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 53:747–753PubMed

84.

Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111:310–314PubMed

85.

Yufu K, Shinohara T, Ebata Y, Ayabe R, Fukui A, Okada N, Nakagawa M, Takahashi N (2015) Endothelial Function Predicts New Hospitalization due to Heart Failure Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol 38:1260–1266PubMed

86.

Santini L, Capria A, Molfetta A, Mahfouz K, Panattoni G, Minni V, Sergi D, Forleo GB, Romeo F (2013) Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure. J Card Fail 19(6):419–425PubMed

87.

Tesselaar E, Schiffer A, Widdershoven J, Broers H, Hendriks E, Luijten K, Creusen J (2012) Effect of Cardiac Resynchronization Therapy on Endothelium-Dependent Vasodilatation in the Cutaneous Microvasculature. Pacing Clin Electrophysiol 35:377–384PubMed

Title: Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation
Authors: G. P. T. Areas
A. Mazzuco
F. R. Caruso
R. B. Jaenisch
R. Cabiddu
S. A. Phillips
R. Arena
A. Borghi-Silva
Publication date: 01-01-2019
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 1/2019
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-018-9719-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis

Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis

Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions

Metabolic remodeling of substrate utilization during heart failure progression

Lanosteryl triterpenes from Protorhus longifolia as a cardioprotective agent: a mini review

Autonomic nervous system in Takotsubo syndrome

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page